HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Applications of major histocompatibility complex class I molecules expressed as single chains.

Abstract
Generation of CD8 T-cell responses to pathogens and tumors requires optimal expression of class I major histocompatibility complex/peptide complexes, which, in turn, is dependent on host cellular processing events and subject to interference by pathogens. To create a stable structure that is more immunogenic and resistant to immune evasion pathways, we have engineered class I molecules as single-chain trimers (SCTs), with flexible linkers connecting peptide, beta2m, and heavy chain. Herein we extend our earlier studies with SCTs to the K(b) ligand derived from vesicular stomatitis virus (VSV) to characterize further SCTs as probes of immune function as well as their potential in immunotherapy. The VSVp-beta2m-K(b) SCTs were remarkably stable at the cell surface, and immunization with DNA encoding SCTs elicited complex-specific antibody. In addition, SCTs were detected by cytotoxic T-lymphocytes specific for the native molecule, and the covalently bound peptide was highly resistant to displacement by exogenous peptide. SCTs can also prime CD8 T-cells in vivo that recognize the native molecule. Furthermore, SCTs were resistant to downregulation by the immune evasion protein mK3 of gamma herpesvirus 68. Moreover, owing to their preassembled nature, SCTs should be resistant to other immune evasion proteins that restrict peptide supply. Thus, SCTs possess therapeutic potential both for prophylactic treatment and for the treatment of ongoing infection.
AuthorsTina Primeau, Nancy B Myers, Y Y Lawrence Yu, Lonnie Lybarger, Xiaoli Wang, Steven M Truscott, Ted H Hansen, Janet M Connolly
JournalImmunologic research (Immunol Res) Vol. 32 Issue 1-3 Pg. 109-21 ( 2005) ISSN: 0257-277X [Print] United States
PMID16106063 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • Histocompatibility Antigens Class I
  • Ligands
  • Recombinant Proteins
  • Vaccines, DNA
Topics
  • Animals
  • Antibody Specificity
  • CD8-Positive T-Lymphocytes (immunology)
  • Histocompatibility Antigens Class I (chemistry, genetics, metabolism)
  • Humans
  • In Vitro Techniques
  • Ligands
  • Mice
  • Models, Molecular
  • Protein Engineering
  • Protein Structure, Quaternary
  • Recombinant Proteins (chemistry, genetics, metabolism)
  • Vaccines, DNA (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: